Blog

  • FDA approves Lytenava for wet AMD
    The FDA approved Lytenava for the treatment of neovascular age-related macular degeneration, according to a press release from Outlook Therapeutics.The approval of Lytenava is marks the first and only FDA-approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the United States.Bevacizumab-vikg, a recombinant humanized IgG1 monoclonal antibody specific for human VEGF, binds […]
  • Microperimetry helps track structure, function in GA
    LAS VEGAS — Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy, according to a presentation at Clinical Trials at the Summit.Arshad Khanani, MD, MA, FASRS, of Sierra Eye Associates in Reno, Nevada, presented initial findings from the first cohort of patients enrolled in the phase 1/2 Opti-GAIN study. The primary […]
  • Dompé evaluating intranasal spray for NAION in phase 3 study
    The first patient has been enrolled in the phase 3 Galassia-NAION-301 study to evaluate an intranasal spray for the treatment of nonarteritic anterior ischemic optic neuropathy, according to a press release from Dompé.If approved, it would be the first FDA-approved treatment for nonarteritic anterior ischemic optic neuropathy (NAION), a spontaneous vision loss that can lead […]
  • All ophthalmologists should help address global visual impairment
    The WHO 2019 report on vision estimates that 36 million people in the world are blind and another 217 million have moderate to severe visual impairment.The International Agency for the Prevention of Blindness states that 1.1 billion of the world’s 8 billion people suffer from visual impairment.About 90% of people with vision impairment live in […]
  • Healio AI, ASCRS partner to expand ophthalmology learning
    Healio AI and the American Society of Cataract and Refractive Surgery, or ASCRS, announced a partnership to optimize available educational resources for ophthalmologists, according to a press release.The collaboration adds the clinical educational content from the 2026 ASCRCS Annual Meeting — which offered over 300 hours of educational opportunities — to Healio AI’s expanding knowledge […]
  • Changes, challenges abound in eye care in developing nations
    Click here to read the Point/Counter to this Cover Story.Through the combined efforts of local governments, pioneering institutions, global health alliances and nongovernmental organizations, the integration of eye care services in low-resource areas of the developing world is making progress.Innovative care delivery models and outreach programs have been successfully implemented, and technological advances have played […]
  • Phase 3 trial to study urcosimod in neuropathic corneal pain
    The FDA favorably reviewed plans for a phase 3 trial of urcosimod, which is being investigated for the treatment of neuropathic corneal pain, according to a press release from Okyo Pharma.The feedback came during a meeting between Okyo Pharma and the FDA, paving the way for a pivotal trial in a disease that currently has […]
  • Lupin recalls more than 2.5 million eye drops
    More than 2.5 million bottles of steroid eye drops aimed at relieving inflammation have been recalled, according to the FDA.Lupin Pharmaceuticals is recalling 2,530,182 bottles of prednisolone acetate ophthalmic solution 1%, including 5 mL, 10 mL and 15 mL bottles. The affected lots have expiration dates ranging from July 31, 2026, to March 31, 2028.The […]
  • Healio wins six APEX awards for publication excellence
    Healio has garnered six APEX awards, including one Grand Award, this year.The APEX awards highlight outstanding achievement in graphic design, editorial content and overall communications excellence. Each year, over 1,000 submissions are selected for Awards of Excellence and Grand Awards.“Our editorial, design, and marketing teams work tirelessly to serve the medical community,” Matthew Holland, chief […]
  • Physician payment reforms ‘a step in the right direction,’ but further change needed
    AMA recently reiterated its call for Congress to pass several reforms that would increase physician payment and improve health care accessibility.During a House Energy and Commerce Subcommittee on Health meeting in May, the AMA advocated for these reforms:Physician payment has declined 33% since 2001, after adjusting for inflation, “and physicians remain the only Medicare provider […]
  • Single sura-vec injection improved early diabetic retinopathy
    PHOENIX — A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according to data presented at Optometry’s Meeting.“Early intervention is essential to prevent progression to blinding complications, yet the burden of frequent intravitreal injections with current anti-VEGF therapies make long-term treatment difficult for many patients,” Steve Pakola, […]
  • What do you wish you knew before starting the innovation process?
    Click here to read the Healio Exclusive, “Ophthalmic innovation: Growing a product from idea to market.”A few years back, one of my surgical partners, Michael Greenwood, MD, and I had an idea for a product that would make things easier for our patients and us. That idea was to show patients what we mean when […]
  • Human stem cell-derived RPE shows safety, improved vision in GA
    DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual improvements in patients with advanced geographic atrophy, according to a speaker.“This study looked at subretinal stem cell implants through a pars plana vitrectomy surgery, where we created a bleb directly over the site of geographic atrophy,” […]
  • Sutureless posterior chamber IOL has good long-term outcomes
    Patients who underwent sutureless scleral fixation of a one-piece IOL had good outcomes at 5 years, according to a study published in Journal of Refractive Surgery.Agostino S. Vaiano, MD, PhD, of Santa Croce e Carle Hospital, Cuneo, Italy, and colleagues wrote that while previous studies have explored both sutured and sutureless posterior chamber IOLs, data […]
  • FDA clears Be Free Day toric contact lenses
    Editor’s note: This is a developing news story. Please check back soon for updates.The FDA cleared Be Free Day toric contact lenses for the correction of myopia and other refractive errors, according to a press release from Euclid Vision.Be Free Day (toufilcon B) silicone hydrogel toric lenses are set to launch this fall with the […]